Skip to content
Buy This GLP
← Research
Formats

Can You Take a GLP-1 Every Two Weeks? What the Evidence Shows

Wegovy injections and Zepbound are labeled for weekly use. A small case series examined less frequent dosing after patients reached a weight plateau.

Editorial profile: Neil SandersBuy This GLP Editorial Team4 min read
U.S. prescribing informationOnce-weekly injectionsWegovy injection and ZepboundReduced frequency studied in a 30-person case series

The U.S. labels specify once-weekly dosing for Wegovy injections and Zepbound. The instructions for a missed weekly injection address an occasional missed dose and vary by product. Ask your prescriber before changing your injection schedule.[1][2]

What a reduced-frequency case series found

Researchers reviewed records for 30 adults whose weight had plateaued during weekly semaglutide or tirzepatide treatment. After switching to less frequent dosing, usually every other week, they were followed on that schedule for an average of 36.3 weeks. Mean weight was 74.1 kg at plateau and 72.4 kg during maintenance. The study included selected patients and had no comparison group that stayed on weekly treatment, so it cannot establish comparable effectiveness or safety.[3]

Studies of a lower weekly maintenance dose address a different change. They can inform a discussion with a prescriber about dose size, while the effects of taking injections less often remain uncertain.

What the bofanglutide trial tested

A 24-week, open-label phase 2b trial in Chinese adults with type 2 diabetes compared bofanglutide with weekly semaglutide 1 mg. HbA1c fell by 2.28 percentage points in the bofanglutide 18 mg every-two-weeks arm and by 1.60 with semaglutide. Gastrointestinal adverse events occurred in 81.8% to 87.3% across all bofanglutide arms, including the weekly arm, and in 51.9% of the semaglutide arm. Gan & Lee Pharmaceuticals funded the trial.[4]

If cost, availability, or side effects are making weekly treatment difficult, discuss those barriers with your prescriber and pharmacist. They can review options for the specific medication and formulation you use.

Frequently asked

Can you take Wegovy injections or Zepbound every two weeks?
The U.S. labels specify once-weekly injections. A small case series of less frequent treatment in selected patients did not establish an equivalent schedule. Ask your prescriber before changing when you inject.
Does the bofanglutide trial apply to Wegovy or Zepbound?
It tested a different drug in adults with type 2 diabetes and cannot establish how often to take semaglutide or tirzepatide.

Sources

  1. [1] Novo Nordisk (2026). Wegovy (semaglutide) prescribing information DailyMed, U.S. National Library of Medicine. Source
  2. [2] Eli Lilly and Company (2026). Zepbound (tirzepatide) prescribing information DailyMed, U.S. National Library of Medicine. Source
  3. [3] Wong M, Wu A, Garhe PK, Biermann M (2026). Reduced-Frequency GLP1 Therapy Maintains Weight, Body Composition, and Metabolic Syndrome Improvements: A Case Series Obesity. Source
  4. [4] Liu M, et al. (2026). Weekly and Biweekly Treatment With Bofanglutide Versus Semaglutide in Chinese Patients With Type 2 Diabetes: A Phase 2b Randomized Clinical Trial Annals of Internal Medicine. PMID 42372276

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Formats